Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis

NCT07228325 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaphylaxis
Allergy

Interventions

DRUG: FMXIN002 single dose
DRUG: Epinephrine autoinjector single dose
DRUG: FMXIN002 single dose + NAC
DRUG: Epinephrine autoinjector double dose
DRUG: FMXIN002 double dose
DRUG: FMXIN002 double dose + NAC

Sponsor

Nasus Pharma